FDA Approval of New Treatment Offers Hope to Millions of Patients Struggling with High Blood Pressure
The only treatment options for high blood pressure have been through lifestyle changes or drug therapy – until now. The FDA recently approved the Medtronic Symplicity™ blood pressure procedure, a minimally invasive blood pressure procedure that offers new hope to the millions of people whose blood pressure isn't managed with medication or lifestyle changes. This comes at a time when drug therapy fails in half of patients after one year.
Dr. Barry Bertolet talks about how the procedure is proven to achieve significant, safe and sustained blood pressure reductions, ushering in a new era for high blood pressure treatment and ultimately offering a new way forward for millions of Americans struggling to manage their blood pressure.
For more information, please visit www.BeyondHBP.com.
Amy Robinson
Medtronic
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
